Home » Topics » BioWorld Science, Patents

BioWorld Science, Patents
RSS

Japanese researchers describe compounds for lipoprotein disorders

Feb. 3, 1997

Neurocrine Bioscience's CRF antagonists for stress-related disorders

Feb. 3, 1997

New CNS agents with 5-HT2C-antagonist activity from Fujisawa

Feb. 3, 1997

Allergan continues research into retinoids and retinoid-like compounds

Feb. 3, 1997

Potent antitumor agents from Takeda

Jan. 31, 1997

Novel antiinfective agents from Tanabe

Jan. 31, 1997

Shaman describes antidiabetic agents from natural source

Jan. 31, 1997

DuPont Merck reports new fibrinogen antagonists

Jan. 31, 1997

CP-0840: Dual-action bradykinin antagonist/mu-opioid agonist from Cortech

Jan. 31, 1997

New anticoagulant drug candidates from Berlex

Jan. 31, 1997

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for May 22, 2026.
Sangamo presents primate data for prion suppressor ST-506
BioWorld Science
Sangamo Therapeutics Inc. discussed gene regulation approaches for neurodegenerative diseases when presenting findings on their clinical candidate ST-506 for the...
TREM2 agonists detailed in Pfizer patent
BioWorld Science
Pfizer Inc. has reported new triggering receptor expressed on myeloid cells 2 (TREM2) agonists potentially useful for the treatment of neurodegeneration.
Unmasking the X: EPAC2 shifts the fragile X landscape
BioWorld
Researchers at UCLA have shown that divergent neuronal signaling in fragile X mice converges on EPAC2, a druggable target whose inhibition restores circuit...
Recludix presents STAT1/3 inhibitors for dermatological diseases
BioWorld Science
Recludix Pharma Inc. recently presented data on their new STAT1/3 inhibitors REX-6553 and REX-6547 for treating dermatological inflammatory skin diseases.